Ellison Mark Jason Heath 4
4 · OPIANT PHARMACEUTICALS, INC. · Filed Jan 9, 2023
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2023-01-09$20.20/sh−469$9,474→ 19,361 total
Footnotes (1)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.